Trial intelligence / Profile preview

Switch Study of Lubiprostone in Elderly Chronic Constipation Patients Using Stimulant Laxatives

jRCTs031200168Completed

Sponsor
Mylan
Start
Jan 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of cobiprostone in chronic constipation, sponsored by Mylan. Primary endpoint: Frequency of spontaneous defecation in the first week after administration of lubiprostone. Started Jan 2021; status: completed.

02

Drugs

cobiprostone
03

Conditions

chronic constipation

Beyond the preview

Go deeper on jRCTs031200168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031200168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call